When the ovarian cancer cell lines were treated with domatinostat at concentrations within the clinically relevant range, the expression levels of FOXM1 mRNA and protein decreased in a concentration-dependent manner (Figure 1a,b), suggesting that domatinostat inhibited FOXM1 expression at the transcriptional level. Here, FOXM1 is linked to ovarian carcinoma.